|
Volumn 65, Issue 12, 2011, Pages 1240-1249
|
A randomised comparison of safety and efficacy of nevirapine vs. atazanavir/ritonavir combined with tenofovir/emtricitabine in treatment-naïve patients
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ATAZANAVIR PLUS RITONAVIR;
CHOLESTEROL;
EMTRICITABINE PLUS TENOFOVIR DISOPROXIL;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
NEVIRAPINE;
TRIACYLGLYCEROL;
ACNE;
ADULT;
AGED;
ARTICLE;
CHOLESTEROL BLOOD LEVEL;
COMPARATIVE STUDY;
CONNECTIVE TISSUE DISEASE;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG ERUPTION;
DRUG FATALITY;
DRUG HYPERSENSITIVITY;
DRUG SAFETY;
DRUG WITHDRAWAL;
EYE DISEASE;
FEMALE;
FOLLOW UP;
GASTROINTESTINAL DISEASE;
HEPATOBILIARY DISEASE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION;
INFECTION;
INFESTATION;
JAUNDICE;
LIVER TOXICITY;
MAJOR CLINICAL STUDY;
MALE;
MEDIASTINUM DISEASE;
MENTAL DISEASE;
MULTICENTER STUDY;
MUSCULOSKELETAL DISEASE;
NEUROLOGIC DISEASE;
PATIENT COMPLIANCE;
PHASE 4 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RESPIRATORY TRACT DISEASE;
SIDE EFFECT;
SKIN DISEASE;
STEVENS JOHNSON SYNDROME;
SUBCUTANEOUS TISSUE DISORDER;
SUICIDAL IDEATION;
SUICIDE ATTEMPT;
THORAX DISEASE;
TOXIC EPIDERMAL NECROLYSIS;
TOXIC HEPATITIS;
TREATMENT RESPONSE;
TRIACYLGLYCEROL BLOOD LEVEL;
ADULT;
ANTI-HIV AGENTS;
DEOXYCYTIDINE;
DRUG COMBINATIONS;
DRUG THERAPY, COMBINATION;
FEMALE;
HIV INFECTIONS;
HIV PROTEASE INHIBITORS;
HUMANS;
LIPID METABOLISM;
MALE;
MIDDLE AGED;
NEVIRAPINE;
OLIGOPEPTIDES;
ORGANOPHOSPHORUS COMPOUNDS;
PYRIDINES;
RITONAVIR;
TREATMENT OUTCOME;
VIRAL LOAD;
YOUNG ADULT;
|
EID: 81755166261
PISSN: 13685031
EISSN: 17421241
Source Type: Journal
DOI: 10.1111/j.1742-1241.2011.02807.x Document Type: Article |
Times cited : (21)
|
References (10)
|